Pulmonary hypertension, nephrotic syndrome, and polymyositis due to hepatitis C virus infection: A case report

Table 1 The patient’s laboratory data at admission and at 1-mo follow-up

Parameter	Value (admission)	Value (month 1)	References value	Unit
N-terminal-pro B-type natriuretic peptide	590		0-125	pg/mL
Urea	10.02	11.6	2.5-6.1	mmol/L
Creatinine	123.4	124.9	46-92	μmol/L
Troponin	< 0.01		0-0.04	ng/mL
Myoglobin	208.1		0-120	ng/mL
Creatine kinase	576.24	98.6	30-135	U/L
Creatine kinase MB isoenzyme	42.1	50.2	0-16	U/L
Lactic dehydrogenase	378.88	777.2	120-246	U/L
D-dimer	1.28		0-0.5	μg/mL
White blood cell	9.10	14.05	4-10	109/L
Platelet	140	111	125-350	109/L
Hemoglobin	119	152	110-150	g/L
Alanine aminotransferase	18.28	41.4	5-40	IU/L
Aspartate aminotransferase	15.44	16.1	8-40	IU/L
Total bilirubin	16.48	30.10	5-21	μmol/L
Direct bilirubin	3.36	7.40	0-3.4	μmol/L
Indirect bilirubin	13.12	22.70	1.6-21	μmol/L
Albumin	22.73	25.65	35-52	g/L
Total cholesterol	7.67		3.0-5.7	mmol/L
Low density lipoprotein cholesterol	3.65		< 4.13	mmol/L
High density lipoprotein cholesterol	2.86		1.29-1.55	mmol/L
Fasting blood glucose	4.44		3.9-6.1	Mmol/L
Urinary protein	4+		negative	-
24-h proteinuria	416.01		0-150	mg/d
Hepatitis B surface antigen	0		< 0.05	IU/mL
Antibody to hepatitis C	6.04		< 1	S/CO
Immunodeficiency virus antigen and antibody	0.09		< 1	S/CO
Antibody to treponema pallidum	0.07		< 1	S/CO
Hepatitis C virus RNA	0		0	IU/mL
Anti-nuclear antibodies	negative		negative	-
Anti-cyclic citrullinated peptide antibody	13.89		< 25	RU/mL
Anti-cardiolipin antibody	2.23		0-12	RU/mL
Immunoglobulin G	4.92		7.51-15.60	g/L
Immunoglobulin A	2.82		0.82-4.53	g/L
Immunoglobulin M	1.81		0.46-3.04	g/L
C3	0.58		0.79-1.52	g/L
C4	0.14		0.16-0.38	g/L
Blood ammonia	56		9-30	μmol/L
Erythrocyte sedimentation rate	22	6	0-20	mm/h